MAPT and Alzheimer disease: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid beta (Aβ) plaques, tau tangles, and significant neuronal/synapse loss, ultimately leading to cognitive decline.